胆总管结扎致肝纤维化模型大鼠肝脏内源性AcSDKP及其调控因子水平的变化

doi:10.13481/j.1671-587x.20180520

吉林大学学报(医学版) ›› 2018, Vol. 44 ›› Issue (05): 999-1004.doi: 10.13481/j.1671-587x.20180520

胆总管结扎致肝纤维化模型大鼠肝脏内源性AcSDKP及其调控因子水平的变化

白洁¹, 纪文静¹, 丁永年¹, 彭媛媛¹, 陈源文²

1. 新疆医科大学第二附属医院消化内科, 新疆乌鲁木齐 830028;
2. 上海交通大学医学院附属新华医院消化内科, 上海 200092

收稿日期:2017-11-21 出版日期:2018-09-28 发布日期:2018-11-20
通讯作者: 陈源文,主任医师,博士研究生导师(Tel:020-25077344,E-mail:shsmus@263.net) E-mail:shsmus@263.net
作者简介:白洁(1983-),女,新疆维吾尔自治区乌鲁木齐市人,主治医师,医学硕士,主要从事消化内科及消化内镜方面的研究。
基金资助:
新疆维吾尔自治区科技厅自然科学基金资助课题（211233146-10）；新疆维吾尔自治区高校科研计划项目资助课题（20120416095630968）

Changes of levelsof endogenous AcSDKP and its regulatory factors in liver tissue of model rats with liver fibrosis induced by bile duct ligation

BAI Jie¹, JI Wenjing¹, DING Yongnian¹, PENG Yuanyuan¹, CHEN Yuanwen²

1. Department of Gastroenterology, Second Affiliated Hospital, Xinjiang Medical University, Urumqi 830028, China;
2. Department of Gastroenterology, Xinhua Hospital, School of Medical Sciences, Shanghai Jiaotong University, Shanghai 200092, China

Received:2017-11-21 Online:2018-09-28 Published:2018-11-20

摘要/Abstract

摘要： 目的：探讨胆总管结扎致肝纤维化模型大鼠肝脏组织中内源性N-乙酰基-丝氨酰-天门冬酰-赖氨酰-脯氨酸（AcSDKP）及相关调控因子水平的变化，阐明AcSDKP在肝纤维化过程中的作用。方法：45只普通级大鼠随机分为模型组、阻断组和对照组，每组15只。模型组采用胆总管结扎建立肝纤维化动物模型；阻断组应用血管紧张素转化酶抑制剂（ACEI）后建立肝纤维化动物模型；对照组予以开腹，但不结扎胆总管。分别在1、2和4周后留取血清及肝组织，检测各组大鼠肝功能指标、肝组织纤维化程度以及肝组织中AcSDKP水平，应用Western blotting法检测各组大鼠肝组织中胸腺素β4、赖氨酸寡肽酶（POP）和血管紧张素转换酶（ACE）水平。结果：自第1周开始，模型组大鼠血清中丙氨酸氨基转移酶（ALT）、门冬氨酸氨基转移酶（AST）、总胆红素（TB）和白蛋白（ALB）水平高于其他2组（P<0.05），而阻断组与对照组比较差异无统计学意义（P>0.05）。自第2周开始，模型组大鼠血清中ALB及肝组织中AcSDKP水平低于其他2组（P<0.05），而阻断组与对照组比较差异无统计学意义（P>0.05）。第1周，3组大鼠肝组织中Ⅲ型前胶原（PCⅢ）、Ⅳ型胶原（CⅣ）和透明质酸（HA）水平比较差异无统计学意义（P>0.05）；第2周，模型组大鼠肝组织中PCⅢ、CⅣ和HA水平高于其他2组（P<0.05），阻断组与对照组上述指标比较差异无统计学意义（P>0.05）。第2周开始，模型组大鼠肝组织中胸腺素β4和ACE蛋白表达水平高于其他2组（P<0.05），而POP蛋白表达水平低于其他2组（P<0.05）；阻断组与对照组上述指标比较差异无统计学意义（P>0.05）。模型组大鼠肝组织中第1周结构基本正常，第2周时呈现小灶状坏死，第4周时呈现片状坏死；阻断组与对照组大鼠肝组织各时间点结构基本正常。结论：胆总管结扎致肝纤维化大鼠肝组织中内源性AcsDKP水平降低可能是通过Tβ4-POP-AcsDKP轴实现的。

关键词: N-乙酰基-丝氨酸-天门冬酰-赖氨酰-脯氨酸, 肝纤维化, 胸腺素β4, 疾病模型,动物

Abstract: Objective:To explore the changes of levels of endogenous N-acetyl-seryl-aspartyl-lysylproline (AcSDKP) and its regulatory factors in liver tissue of rats with liver fibrosis induced by bile duct ligation, and to elucidate the effect of endogenous AcSDKP in the pathologic process of liver fibrosis. Methods:Forty-five healthy male rats were randomly divided into model group (the liver fibrosis rat models were set up by bile duct ligation), blocking group (the liver fibrosis rat models were treated with angiotensin-converting enzyme inhibitor before) and control group (the rats received laparotomy but not bile duct ligation); each group had 15 rats. The serum and liver tissue of the rats in various groups were gained at the 1st week, 2nd week and 4th week. The differences in the indexes of liver function, the liver fibrosis degrees,and the AcSDKP levels in liver tissue of the rats in various groups were analyzed. The levels of thymosin beta 4 (Tβ4), prolyl oligopeptidase (POP) and angiotensin converting enzyme (ACE) in liver tissue of the rats in various groups were detected by Western blotting. Results:The levels of alanine aminotransferase(ALT),aspartate aminotransferase(AST) and total bilirubin(TB) of the rats in model group were higher than those in other two groups from the 1st week (P<0.05), and there were no differences between blocking group and control group (P>0.05). The ALB and the AcSDKP level in liver tissue of the rats in model group were lower than those in other two groups from the 2nd week (P<0.05), and there were no differences between blocking group and control group (P>0.05).The levels procollagen type Ⅲ(PCⅢ), collagen type Ⅳ(CⅣ) and hyaluronic acid(HA) in three groups had no differences at the 1st week (P>0.05). The levels of PCⅢ, CⅣ, and HA of the rats in model group were higher than those in other two groups from the 2nd week (P<0.05), and there were no differences between blocking group and control group (P>0.05). The levels of Tβ4 and ACE in liver tissue of the rats in model group were higher than those in other two groups from the 2nd week (P<0.05), and the level of POP of model group were lower than those in other two groups from the 2nd week (P<0.05), but there were no differences between blocking group and control group (P>0.05). The liver tissue of the rats in model group was basically normal at the 1st week, showed the focal necrosis at the 2nd week, and showed the flake necrosis at the 4th week. The liver tissue of the rats in blocking group and control group were basically normal at all time points. Conclusion:The endogenous AcSDKP level in the liver fibrosis rats induced by bile duct ligation is down-regulated through the axis of Tβ4-POP-AcsDKP.

Key words: N-acetyl-seryl-aspartyl-lysylproline, liver fibrosis, thymosin beta 4, disease model,animals

中图分类号:

R575

白洁, 纪文静, 丁永年, 彭媛媛, 陈源文. 胆总管结扎致肝纤维化模型大鼠肝脏内源性AcSDKP及其调控因子水平的变化[J]. 吉林大学学报(医学版), 2018, 44(05): 999-1004.

BAI Jie, JI Wenjing, DING Yongnian, PENG Yuanyuan, CHEN Yuanwen. Changes of levelsof endogenous AcSDKP and its regulatory factors in liver tissue of model rats with liver fibrosis induced by bile duct ligation[J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 999-1004.

参考文献

[1] Kanasaki K, Nagai T, Nitta K, et al. N-acetyl-seryl-aspartyl-lysyl-proline:a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes[J]. Front Pharmacol, 2014, 5:70-81.
[2] Hrenak J, Paulis L, Simko F. N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP):Potential target molecule in research of heart, kidney and brain[J]. Curr Pharm Des, 2015, 21(35):5135-5143.
[3] Mnguni AT, Engel ME, Borkum MS, et al. The effects of angiotensin converting enzyme inhibitors (ACE-I) on human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) levels:a systematic review and Meta-Analysis[J]. PLoS One, 2015, 10(12):e0143338.
[4] Mnguni AT, Engel ME, Borkum MS, et al. The Effects of Angiotensin Converting Enzyme Inhibitors (ACE-I) on Human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Levels:A Systematic Review and Meta-Analysis[J]. PLoS One, 2015, 10(12):e0143338.
[5] 刘晓亚,刘瑞霞,崔立建,等.胆管结扎和四氯化碳诱导Wistar大鼠肝纤维化模型的建立及相关指标的对比分析[J].临床肝胆病杂志,2015,31(2):219-224.
[6] Chen YW, Liu BW, Zhang YJ, et al. Preservation of basal AcSDKP attenuates Carbon tetrachloride-induced fibrosis in the rat liver[J]. J Hepatol, 2010, 53(3):528-536.
[7] Yuan J, Shen Y, Yang X, et al. Thymosin β4 alleviates renal fibrosis and tubular cell apoptosis through TGF-β pathway inhibition in UUO rat models[J]. BMC Nephrol, 2017, 18(1):314-324.
[8] Zhu L, Cheng M, Liu Y, et al. Thymosin-β4 inhibits proliferation and induces apoptosis of hepatic stellate cells through PI3K/AKT pathway[J]. Oncotarget, 2017, 8(40):68847-68853.
[9] Deng H, Xu H, Zhang X, et al. Protective effect of Ac-SDKP on alveolar epithelial cells through inhibition of EMT via TGF-β1/ROCK1 pathway in silicosis in rat[J]. Toxicol Appl Pharmacol, 2016, 294:1-10.
[10] Mitrovic V, Seferovic P, Dodic S, et al. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure[J]. Circ Heart Fail, 2009, 2(6):523-531.
[11] Stienstra R, Saudale F, Duval C, et al. Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity[J]. Hepatology, 2010, 51(2):511-522.
[12] Hu Q, Li J, Nitta K, et al. FGFR1 is essential for N-acetyl-seryl-aspartyl-lysyl-proline regulation of mitochondrial dynamics by upregulating microRNA let-7b-5p[J]. Biochem Biophys Res Commun, 2018, 495(3):2214-2220.
[13] Masuyer G, Douglas RG, Sturrock ED, et al. Structural basis of Ac-SDKP hydrolysis by Angiotensin-Ⅰ converting enzyme[J]. Sci Rep, 2015, 5:13742.
[14] Srivastava SP, Shi S, Kanasaki M, et al. Effect of antifibrotic MicroRNAs crosstalk on the action of n-acetyl-seryl-aspartyl-lysyl-proline in diabetes-related kidney fibrosis[J]. Sci Rep, 2016, 6:29884.doi:10.1038/srep 29884.
[15] Li J, Shi S, Srivastava SP, et al. FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway[J]. Cell Death Dis, 2017, 8(8):e2965.
[16] 闫静波.AcSDKP对硅肺纤维化大鼠胶原含量及NF-κBp65表达的影响[J].重庆医学,2013(26):3139-3141.
[17] Conte E, Fagone E, Gili E, et al. Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis[J]. Oncotarget, 2016, 7(23):33841-33854.
[18] Liao TD, Nakagawa P, Janic B, et al. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline:mechanisms of renal protection in mouse model of systemic lupus erythematosus[J]. Am J Physiol Renal Physiol, 2015, 308(10):F1146-F1154.
[19] Ma X, Yuan Y, Zhang Z, et al. An analog of Ac-SDKP improves heart functions after myocardial infarction by suppressing alternative activation (M2) of macrophages[J]. Int J Cardiol, 2014, 175(2):376-378.
[20] Monge M, Paquet V, Bergerot D, et al. Dose-effect relationship of perindopril 10, 14 and 20mg assessed by urine and plasma AcSDKP levels in mildly sodium-depleted healthy volunteers[J]. Int J Cardiol, 2016, 222:648-653.
[21] 牛学敏,王宝玉,王洋,等.PTEN在CCl_4诱导肝纤维化大鼠模型中的作用及益气活血方对其的影响[J].临床肝胆病杂志,2018,34(1):122-128.
[22] Jiang Y, Han T, Zhang ZG, et al. Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease[J]. Chronic Dis Transl Med, 2017, 3(3):165-168.
[23] Hong Y, Yao Q, Zheng L. Thymosin β4 attenuates liver fibrosis via suppressing Notch signaling[J]. Biochem Biophys Res Commun, 2017, 493(4):1396-1401.

胆总管结扎致肝纤维化模型大鼠肝脏内源性AcSDKP及其调控因子水平的变化

Changes of levelsof endogenous AcSDKP and its regulatory factors in liver tissue of model rats with liver fibrosis induced by bile duct ligation

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 12

Metrics

本文评价

推荐阅读 0

[1]	牛猛, 邓大勇, 李云鹏飞, 刘硕, 丁军. 磁共振弹性成像对肝纤维化分级诊断价值的Meta分析[J]. 吉林大学学报(医学版), 2017, 43(04): 787-793.
[2]	常彩芳, 候勇, 丛刚. α-2b干扰素对乙型肝炎模型鸭肝组织炎症和肝纤维化的治疗作用[J]. 吉林大学学报(医学版), 2017, 43(01): 11-15.
[3]	张宸豪, 李瑶, 陈为, 赵良中, 李妍. FTY720对实验性肝纤维化小鼠肝损伤的保护作用[J]. 吉林大学学报(医学版), 2015, 41(06): 1154-1157.
[4]	杨坤, 田珍珍, 王淑华, 修明, 郭乡羚, 齐丽娜, 李敏, 孙丽, 高润平. LPS-TLR4信号通路在慢性酒精摄入大鼠模型肝纤维化发生中的作用及其机制[J]. 吉林大学学报(医学版), 2015, 41(04): 751-755.
[5]	郝晓方, 张荣花, 王琳, 王梅梅, 甄永占, 章广玲, 陈静. 赖氨大黄酸对胆汁淤积性肝纤维化模型大鼠的治疗作用及其分子机制[J]. 吉林大学学报(医学版), 2015, 41(03): 481-485.
[6]	魏洁, 李开济, 骆广玲, 魏静波, 李保卫, 何红伟, 甄永占. 姜黄素对实验性肝纤维化大鼠肝损伤的保护作用[J]. 吉林大学学报(医学版), 2015, 41(02): 225-229.
[7]	. 低分子壳聚糖的抗肝纤维化作用及其对TLR4表达的影响[J]. 吉林大学学报(医学版), 2014, 40(05): 1013-1017.
[8]	李宜轩，陈建光，李凤，曲绍春，于晓风，睢大筼. 北五味子提取物对实验性肝纤维化大鼠肝损伤的保护作用[J]. 吉林大学学报(医学版), 2014, 40(02): 285-288.
[9]	钟志宏，颜文贞，戴东，陈土明，胡祖超. 雷帕霉素对四氯化碳油致肝纤维化模型大鼠的治疗作用[J]. 吉林大学学报(医学版), 2013, 39(6): 1224-1227.
[10]	吴江锋, 张艳琼, 柳长柏, 肖和杰. 抗肝纤冲剂对肝纤维化小鼠Ⅰ型胶原蛋白表达的影响[J]. J4, 2010, 36(4): 651-655.
[11]	戴永美, 蔡立勉, 林棱 . 奥曲肽对大鼠肝星状细胞增殖的抑制作用[J]. J4, 2009, 35(6): 1052-1056.
[12]	牛铁兵, 陈玉丙, 张立新. 骨髓间充质干细胞移植对大鼠肝纤维化模型的修复作用[J]. J4, 2009, 35(5): 874-876.